Tempest Therapeutics, Inc. Increase (Decrease) in Accounts Payable, Trade
Tempest Therapeutics, Inc. (TPST) reported Increase (Decrease) in Accounts Payable, Trade of $957.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2026-08-13
- Tempest Therapeutics, Inc. increase (decrease) in accounts payable, trade for the quarter ending 2026-06-30 was $1.41M, a 44.21% decline year-over-year.
- Tempest Therapeutics, Inc. increase (decrease) in accounts payable, trade for the quarter ending 2026-03-31 was -$454.00K.
- Tempest Therapeutics, Inc. increase (decrease) in accounts payable, trade for the quarter ending 2025-12-31 was $116.00K, a 84.59% decline year-over-year.
- Tempest Therapeutics, Inc. increase (decrease) in accounts payable, trade for the quarter ending 2025-09-30 was -$3.79M, a 1215.88% decline year-over-year.
- Tempest Therapeutics, Inc. increase (decrease) in accounts payable, trade for fiscal 2025 was -$1.41M, a 187.98% decline from fiscal 2024.
- Tempest Therapeutics, Inc. increase (decrease) in accounts payable, trade for fiscal 2024 was $1.60M.
- Tempest Therapeutics, Inc. increase (decrease) in accounts payable, trade for fiscal 2023 was -$263.00K, a 26400.00% decline from fiscal 2022.
- Tempest Therapeutics, Inc. increase (decrease) in accounts payable, trade for fiscal 2022 was $1.00K.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 3 month as first filed | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 6 month as first filed | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 9 month as first filed | Increase (Decrease) in Accounts Payable, Trade 12 month | Increase (Decrease) in Accounts Payable, Trade 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $957.00K 10-Q · filed 2026-08-13 | $1.07M derived: sum of 3 quarters · filed 2026-08-13 | -$2.72M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$454.00K 10-Q · filed 2026-05-14 | -$338.00K derived: sum of 2 quarters · filed 2026-05-14 | -$4.13M derived: sum of 3 quarters · filed 2026-05-14 | -$1.60M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$3.68M derived: sum of 2 quarters · filed 2026-03-30 | -$1.15M derived: sum of 3 quarters · filed 2026-08-13 | -$1.41M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | -$3.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.26M derived: sum of 2 quarters · filed 2026-08-13 | -$1.53M 10-Q · filed 2025-11-05 | -$775.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $2.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $2.27M 10-Q · filed 2026-08-13 | $3.02M derived: sum of 3 quarters · filed 2026-08-13 | $3.36M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$263.00K 10-Q · filed 2026-05-14 | $490.00K derived: sum of 2 quarters · filed 2026-05-14 | $830.00K derived: sum of 3 quarters · filed 2026-05-14 | $1.14M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $753.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.09M derived: sum of 2 quarters · filed 2026-03-30 | $1.40M derived: sum of 3 quarters · filed 2026-03-30 | $1.60M 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $340.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $646.00K derived: sum of 2 quarters · filed 2025-11-05 | $852.00K 10-Q · filed 2025-11-05 | $561.00K derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | $306.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $512.00K 10-Q · filed 2025-08-11 | $221.00K derived: sum of 3 quarters · filed 2025-08-11 | $489.00K derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | $206.00K 10-Q · filed 2025-05-13 | -$85.00K derived: sum of 2 quarters · filed 2025-05-13 | $183.00K derived: sum of 3 quarters · filed 2025-05-13 | -$69.00K derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | -$291.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$23.00K derived: sum of 2 quarters · filed 2025-03-27 | -$275.00K derived: sum of 3 quarters · filed 2025-03-27 | -$263.00K 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | $268.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $16.00K derived: sum of 2 quarters · filed 2024-11-12 | $28.00K 10-Q · filed 2024-11-12 | $118.00K derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$252.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$240.00K 10-Q · filed 2024-08-08 | -$150.00K derived: sum of 3 quarters · filed 2024-08-08 | -$677.00K derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $12.00K 10-Q · filed 2024-05-09 | $102.00K derived: sum of 2 quarters · filed 2024-05-09 | -$425.00K derived: sum of 3 quarters · filed 2024-05-09 | $336.00K derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$437.00K derived: sum of 2 quarters · filed 2024-03-19 | $324.00K derived: sum of 3 quarters · filed 2024-03-19 | $1.00K 10-K · filed 2024-03-19 | ||||
| 2022-09-30 | -$527.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $234.00K derived: sum of 2 quarters · filed 2023-11-08 | -$89.00K 10-Q · filed 2023-11-08 | -$1.43M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $761.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $438.00K 10-Q · filed 2023-08-10 | -$901.00K derived: sum of 3 quarters · filed 2023-08-10 | -$5.22M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$323.00K 10-Q · filed 2023-05-10 | -$1.66M derived: sum of 2 quarters · filed 2023-05-10 | -$5.98M derived: sum of 3 quarters · filed 2023-05-10 | -$218.00K derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | -$1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$5.65M derived: sum of 2 quarters · filed 2023-03-22 | $105.00K derived: sum of 3 quarters · filed 2023-03-22 | -$209.00K 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | -$4.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $1.44M derived: sum of 2 quarters · filed 2022-11-08 | $1.13M 10-Q · filed 2022-11-08 | $1.29M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $5.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $5.45M 10-Q · filed 2022-08-15 | $5.61M derived: sum of 3 quarters · filed 2022-08-15 | $5.76M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | -$314.00K 10-Q · filed 2022-05-13 | -$669.00K 10-Q · filed 2021-05-13 | -$151.00K derived: sum of 2 quarters · filed 2022-05-13 | $3.00K derived: sum of 3 quarters · filed 2022-05-13 | -$2.22M derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-12-31 | $163.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $317.00K derived: sum of 2 quarters · filed 2022-03-29 | -$1.90M derived: sum of 3 quarters · filed 2022-03-29 | -$574.00K 10-K · filed 2022-03-29 | $25.00K 10-K · filed 2021-03-29 | |||
| 2020-09-30 | $154.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$2.07M derived: sum of 2 quarters · filed 2021-11-10 | -$737.00K 10-Q · filed 2021-11-10 | $280.00K 10-Q · filed 2020-11-09 | -$2.02M derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | -$2.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$891.00K 10-Q · filed 2021-08-12 | -$88.00K 10-Q · filed 2020-08-10 | -$2.17M derived: sum of 3 quarters · filed 2021-08-12 | -$2.42M derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | $1.33M 10-Q · filed 2021-05-13 | $48.00K derived: sum of 2 quarters · filed 2021-05-13 | -$196.00K derived: sum of 3 quarters · filed 2021-05-13 | $462.00K derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | -$1.52M derived: sum of 2 quarters · filed 2021-03-29 | -$867.00K derived: sum of 3 quarters · filed 2021-03-29 | -$469.00K 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | -$244.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $414.00K derived: sum of 2 quarters · filed 2020-11-09 | $812.00K 10-Q · filed 2020-11-09 | $1.06M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | $658.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $1.06M 10-Q · filed 2020-08-10 | $1.31M derived: sum of 3 quarters · filed 2020-08-10 | $1.74M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $398.00K 10-Q · filed 2020-05-08 | $651.00K derived: sum of 2 quarters · filed 2020-05-08 | $1.08M derived: sum of 3 quarters · filed 2020-05-08 | $920.00K derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | $253.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $687.00K derived: sum of 2 quarters · filed 2020-03-11 | $522.00K derived: sum of 3 quarters · filed 2020-03-11 | $320.00K 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | $434.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $269.00K derived: sum of 2 quarters · filed 2019-11-13 | $67.00K 10-Q · filed 2019-11-13 | |||||
| 2018-06-30 | -$165.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$367.00K 10-Q · filed 2019-08-12 | ||||||
| 2018-03-31 | -$202.00K 10-Q · filed 2019-05-15 | |||||||
| 2017-12-31 | -$1.45M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |